Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells

Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Mol Sci
Hauptverfasser: Codini, Michela, Conte, Carmela, Cataldi, Samuela, Arcuri, Cataldo, Lazzarini, Andrea, Ceccarini, Maria Rachele, Patria, Federica, Floridi, Alessandro, Mecca, Carmen, Ambesi-Impiombato, Francesco Saverio, Beccari, Tommaso, Curcio, Francesco, Albi, Elisabetta
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://ncbi.nlm.nih.gov/pubmed/30388783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113424
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge